0001349943-18-000006.txt : 20180803
0001349943-18-000006.hdr.sgml : 20180803
20180803140748
ACCESSION NUMBER: 0001349943-18-000006
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180801
FILED AS OF DATE: 20180803
DATE AS OF CHANGE: 20180803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanders Walter Lloyd
CENTRAL INDEX KEY: 0001349943
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 18991363
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
3
1
edgardoc.xml
PRIMARY DOCUMENT
X0206
3
2018-08-01
0
0000899923
MYRIAD GENETICS INC
MYGN
0001349943
Sanders Walter Lloyd
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
President Myriad Oncology
Common Stock
24961
D
Incentive Stock Option (right to buy)
26.49
2017-09-17
2021-09-17
Common Stock
3775
D
Incentive Stock Option (right to buy)
27.07
2016-09-12
2022-09-12
Common Stock
3694
D
Non-Qualified Stock Option (right to buy)
26.49
2017-09-17
2021-09-17
Common Stock
16850
D
Non-Qualified Stock Option (right to buy)
27.07
2016-09-12
2022-09-12
Common Stock
5056
D
By: Richard Marsh For: Walter Sanders
2018-08-03
EX-24
2
powerofattorneysanders.txt
EDGAR SUPPORTING DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned
hereby constitutes and appoints each of Richard
M. Marsh, R. Bryan Riggsbee and Nathan A. Smith
of Myriad Genetics, Inc. the Company, and Jonathan
L. Kravetz, Daniel Follansbee and Pamela Greene of
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.,
signing singly, with full power of substitution,
the undersigned s true
and lawful attorney-in-fact to:
1 execute for and on behalf of the undersigned,
forms and authentication documents for EDGAR Filing Access;
2 do and perform any and all acts for and
on behalf of the undersigned which may be necessary
or desirable to complete and execute any such forms
and authentication documents;
3 execute for and on behalf of the undersigned,
in the undersigned's capacity as an officer, director
and/or 10% shareholder of the Company,
Forms 3, 4 and 5 in accordance with Section
16a of the Securities Exchange Act of 1934 and the
rules thereunder;
4 do and perform any and all acts for and on
behalf of the undersigned which may be necessary
or desirable to complete and execute any such
Form 3, 4 or 5 and timely file such form with
the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
5 take any other action of any type whatsoever
in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the undersigned,
it being understood that the documents executed by
such attorney-in-fact, on behalf of the undersigned
pursuant to this Power of Attorney, shall be in such
form and shall contain such terms and conditions
as such attorney-in-fact may approve in such
attorney-in-fact s discretion.
The undersigned hereby grants to each such
attorney-in-fact full power and authority
to do and perform any and every act and
thing whatsoeverrequisite, necessary, or
proper to be done in the exercise of any
of the rights and powers herein granted,
as fully to all intents and purposes
as the undersigned might or could do if personally
present, with full power of substitution or
revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such attorney-in-facts
substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power
of attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such
capacity at the request of the undersigned, is
not assuming, nor is the Company assuming, any
of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer
required to file Forms 3, 4 and 5 with respect
to the undersigned's holdings of and transactions
in securities issued by the Company, unless
earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed this
13th day of July, 2018.
/s/ Walter Lloyd Sanders
Walter Lloyd Sanders